Over There: Sanofi-Aventis Details Plans for Emerging Markets
This article was originally published in The Pink Sheet Daily
Executive Summary
Citing a "competitive advantage," Sanofi aims to double sales in new markets from €6.5 billion in 2008 to €17 billion by 2013.
You may also be interested in...
Western Firms Prepare To Capitalize On Chinese Reimbursement Reform
Western drug-makers are positioning themselves to capitalize on a multi-billion dollar health care reform program outlined by the Chinese government earlier this year
Western Firms Prepare To Capitalize On Chinese Reimbursement Reform
Western drug-makers are positioning themselves to capitalize on a multi-billion dollar health care reform program outlined by the Chinese government earlier this year
Western Firms Prepare to Exploit Chinese Reimbursement Reform
Western drugmakers are positioning themselves to exploit a multi-billion dollar healthcare reform program outlined by the Chinese government late last year